To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa2100
Peptide Name Sequence 8 from Patent US8883480B2
Sequence HPOFLSL
Sequence Length 7
Source Synthetic peptide
Target Organism H9N2
Patent Type Granted Patent
Publication Date 2014-11-11
Patent No US8883480B2
Family Info WO2009151313A1, MY160435A, JP5647111B2, DK2300492T3, EP2300492B1
Patent Title Antiviral peptide against avian influenza virus H9N8
Comment
Abstract The present invention relates to recombinant phages carrying fusion peptides that bind to avian influenza virus (AIV). Such phages are useful as diagnostic reagents to replace anti-AIV antibodies because the phages are capable of competing with the latter antibodies for binding sites on the virus. Synthetic peptides with the sequence CNDFRSKTC, either in linear or cyclic conformations, or fusion phages bearing the above said peptides inhibited AIV propagation in embryonated egg as well as in MDCK cell lines. Therefore they may be used as'therapeutic agents to control, to treat and to eradicate bird flu caused by avian influenza virus.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.